Experimental Drug Inhibits or Prevents Diabetic Eye Disease in Wilmer Eye Institute Study
2024-11-14 16:16:16
Artistic rendition of diabetic eye disease highlighting vascular changes (i.e., retinal neovascularization) observed in patients with proliferative diabetic retinopathy. Credit: Isabella S. Sodhi, McDonogh School
News from our full member the Wilmer Eye Institute – Johns Hopkins
Research from Akrit Sodhi and colleagues shows that an experimental drug may prevent or slow vision loss in people with diabetes.
More information here!
Source and image: Wilmer Eye Institute – Johns Hopkins
More news
How to log in for the Annual Meeting
Last things to do before you leave for the 18th Annual Meeting! See the key points below! WAEH 18th Annual Meeting Tips for travelling WAEH 18th Annual Meeting China in […]
WAEH 18th Annual Meeting
Going with the bullet train from Changsha to Shanghai? Please send us a copy of your passport if not done already! If you’d like to take the bullet train from […]
News from our member L V Prasad Eye Institute
The Liberia Eye Center Liberia, in Western Africa, has an estimated age-standardised prevalence of vision loss of 17% (all causes). India has about 22%, but with a population that is […]
Christine Nelson, M.D., received the Women in Ophthalmology (WIO) Humanitarian Award!
News from our member Kellogg Eye Center In recognition of a career of dedicated service, Christine Nelson, M.D., was presented with the Women in Ophthalmology (WIO) Humanitarian Award. The annual […]
WAEH Newsletter October
WAEH 18th Annual Meeting Register now and check this carefully!! Important Visa Information Please ensure that you check whether you need a visa for your upcoming trip. Some countries, including […]